Current stock page

Catalysts

LIVN Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

LIVNLivaNova PLC

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 9/10
$94.54+$2.62 (+2.85%)

Latest quote

  • Momentum
    83
  • Value
    60
  • Quality
    64
  • Risk resilience
    71
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 24, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 71/100

Momentum 83/100 and sentiment — before the next covered event.

Recent coverage
5 articles

Updated Nov 18, 2026 · Sentiment 37.19%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 83/100AIQ Edge 9/10 Strong Relative Position
Beat rate
100%
8 of 8 reported periods
Average surprise
+14.8%
Across covered historical reports
Latest result
+16.0%
Nov 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—$1.06$1.23+16.0%$381.13M$393.1M
Aug 5, 2026—$1.09$1.26+15.6%$380.5M$390.6M
May 6, 2026—$0.85$0.98+15.3%$346.05M$362.3M
Feb 25, 2026—$0.80$0.86+7.5%$353.3M$360.9M
Nov 5, 2025—$0.92$1.11+20.8%$342.72M$357.8M
Aug 6, 2025—$0.84$1.05+25.0%$332.22M$352.5M
May 7, 2025—$0.75$0.88+17.3%$302.42M$316.9M
Feb 25, 2025—$0.80$0.81+1.3%$308.66M$321.8M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
9
Buy
2
Hold
1
Sell
12-month analyst target
$107.50
+13.71% versus current price
Based on 12 analyst observations. Targets are estimates, not predictions.
Low target
$90.00
-4.80% vs latest price
Average target
$107.50
+13.71% vs latest price
High target
$120.00
+26.93% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 24, 2027

Next known earnings or reporting date.

EPS estimate$0.98

Current analyst expectation for the upcoming report.

Revenue estimate$389.18M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score83

Where event reaction would show up first.

AIQ score71/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
12
Average target
$107.50
Target upside
13.71%
Target range
$90.00 - $120.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
5
Neutral
0
Negative
0
seekingalpha.com · Nov 12, 2026

LivaNova: Paying Off The Last Legacy Bill Just As The Sleep Apnea Market Opens Up

The bull case for LivaNova: 2026 guidance calls for 9%-10% revenue growth and 14% adjusted EPS growth; OSA's 2027 launch could add upside. Click for more on LIVN stock.

seekingalpha.com · Nov 9, 2026

LivaNova PLC (LIVN) Presents at 2026 UBS Global Healthcare Conference Transcript

LivaNova PLC (LIVN) 2026 UBS Global Healthcare Conference November 9, 2026 11:00 AM ESTCompany ParticipantsAlex Shvartsburg - Chief Financial OfficerPhilip...

gurufocus.com · Nov 9, 2026

LIVN Maintained by Barclays -- Price Target Raised to $120

LivaNova (LIVN) Analyst Rating Update - November 9, 2026 On November 9, 2026, Barclays maintained an Overweight rating on LivaNova (LIVN) while raising the p

gurufocus.com · Oct 23, 2026

LivaNova (LIVN) Publishes 36-Month CORE-VNS Study Results on Drug-Resistant Epilepsy

On October 23, 2026, LivaNova PLC (NASDAQ: LIVN) announced the publication of comprehensive 36-month follow-up results from the CORE-VNS study in the journal Ne

gurufocus.com · Sep 14, 2026

LivaNova PLC at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 03:30PM GMTNeha Begwani - Morgan Stanley - Managing Director - Healthcare Investment Banking Perfect. I think we'll get going here. First, just a

Open full news and sentiment

LIVN Catalysts FAQ

What are the next catalysts for LIVN stock?

LIVN's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move LIVN stock?

Upcoming events that could move LIVN include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could LIVN's next earnings report affect the stock?

LIVN's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive LIVN stock higher?

LIVN could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt LIVN stock?

LIVN could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.